Omeprazole in Pregnancy: Safety, Risks & Clinical Guidance
Omeprazole, a proton‑pump inhibitor (PPI), treats gastroesophageal reflux disease (GERD), peptic ulcers, and hypersecretory conditions. Current evidence suggests it is generally safe during pregnancy, but a nuanced risk‑benefit assessment is essential.
Safety Data
- Large cohort studies and meta‑analyses show no significant increase in major congenital malformations with first‑trimester PPI exposure.
- A few studies reported a possible association with gastroschisis (abdominal wall defect), but findings are inconsistent and may reflect confounding.
- The FDA classifies omeprazole as Pregnancy Category C (animal data show risk, human data limited), but clinical guidelines consider it compatible when benefits outweigh risks.
Clinical Recommendations
- Non‑drug measures first: dietary modification, elevation of head of bed, small frequent meals.
- If medication needed: omeprazole 20 mg daily is the best‑studied PPI in pregnancy.
- Lowest effective dose, shortest duration.
- Consult obstetrician/provider before starting or continuing any medication.
Individual Factors
Safety can vary by gestational age, dose, maternal comorbidities, and concomitant medications. Shared decision‑making with a healthcare professional is crucial.
Prescription Medications - Related Articles
- Clarifoam for Rosacea: Treatment, Uses & Effectiveness
- Accessing Your Pharmacy Records: A Simple Guide
- AED Use: Removing Medication Patches for Safe Shock Delivery
- Male Enhancement Pills: Common Ingredients and Safety Considerations
- Discontinuing Mobic (Meloxicam): A Guide to Safe Withdrawal
- FDA REMS Requirements: A Comprehensive Guide for Drug & Biologic Approval
- Vertigo Medications: Understanding Treatment Options
